Sponsor Pipeline

Shin Poong Pharmaceutical Co. Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
2
Recruiting
1
Phase 3
4
Disease Areas
Active Trials by Phase
Phase 3
1
Phase 2
2
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06660719 Efficacy and Safety of SP-8203 (Otaplimastat) in Patients With Acute Ischemic Stroke… Ischemic Stroke Recruiting
Phase 2
NCT06826872 Efficacy and Safety of SPC1001 in Patients With Essential Hypertension Hypertension, Essential Recruiting
NCT07064525 Evaluate the Efficacy and Safety of SPC1001 Low in Patients With Essential Hypertension Hypertension (HTN) Enrolling by Invitation
Disease Areas
Hypertension (2) Stroke (1) Heart Disease (1) Heart Failure (1)
Get alerts when Shin Poong Pharmaceutical Co. Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free